Literature DB >> 20435064

Experimental identification of microRNA targets on the 3' untranslated region of human FMR1 gene.

Yong-Hong Yi1, Xun-Sha Sun, Jia-Ming Qin, Qi-Hua Zhao, Wei-Ping Liao, Yue-Sheng Long.   

Abstract

FMR1 gene plays an important role in the development of central nervous system. Down-regulation of the FMR1 expression leads to fragile X syndrome. MicroRNAs (miRNAs) can repress gene expression by base pairing with their mRNA targets. By computer programs analysis, five miRNAs: miR-19a, miR-19b, miR-142, miR-302b* and miR-323-3p potentially target to different sites on the FMR1 3' untranslated region (3' UTR), except that miR-19a and miR-19b share the same targeting site. To test whether these miRNAs repress reporter gene expression by interacting with the miRNA targets on the FMR1 3' UTR, we developed two chimeric constructs: one construct expressing a firefly luciferase with the FMR1 3' UTR or its miRNA target mutations and the other construct expressing a pre-miRNA fusing with GFP. Luciferase assay co-transfecting with the two constructs showed that the miRNAs, miR-19b, miR-302b* and miR-323-3p could repress gene expression in HEK-293 cells, suggesting a role of these miRNAs in the regulation of the FMR1 expression. The constructs used in this study can be widely used to identify the miRNA targets in any interested genes, which will greatly promote the current progress in understanding the biological function of miRNAs. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435064     DOI: 10.1016/j.jneumeth.2010.04.022

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  9 in total

Review 1.  Functions of noncoding RNAs in neural development and neurological diseases.

Authors:  Shan Bian; Tao Sun
Journal:  Mol Neurobiol       Date:  2011-10-04       Impact factor: 5.590

2.  Computational identification and experimental validation of microRNAs binding to the fragile X syndrome gene Fmr1.

Authors:  Xi Gong; Yanlu Wang; Jianping Zeng; Siguang Li; Yuping Luo
Journal:  Neurochem Res       Date:  2014-11-07       Impact factor: 3.996

Review 3.  The Potential Role of miRNAs as Predictive Biomarkers in Neurodevelopmental Disorders.

Authors:  Iman Imtiyaz Ahmed Juvale; Ahmad Tarmizi Che Has
Journal:  J Mol Neurosci       Date:  2021-03-27       Impact factor: 3.444

Review 4.  Practical Aspects of microRNA Target Prediction.

Authors:  T M Witkos; E Koscianska; W J Krzyzosiak
Journal:  Curr Mol Med       Date:  2011-03       Impact factor: 2.222

5.  Chemokine receptor CCR6 expression is regulated by miR-518a-5p in colorectal cancer cells.

Authors:  Claudia Rubie; Bianca Kruse; Vilma Oliveira Frick; Kathrin Kölsch; Pirus Ghadjar; Mathias Wagner; Friedrich Grässer; Stefan Wagenpfeil; Mathias Glanemann
Journal:  J Transl Med       Date:  2014-02-21       Impact factor: 5.531

Review 6.  Altered Translational Control of Fragile X Mental Retardation Protein on Myelin Proteins in Neuropsychiatric Disorders.

Authors:  Se Jin Jeon; Jong Hoon Ryu; Geon Ho Bahn
Journal:  Biomol Ther (Seoul)       Date:  2017-05-01       Impact factor: 4.634

7.  MiR-323a-3p acts as a tumor suppressor by suppressing FMR1 and predicts better esophageal squamous cell carcinoma outcome.

Authors:  Yu Men; Yirui Zhai; Lihong Wu; Lipin Liu; Wenjue Zhang; Wei Jiang; Nan Bi; Yongmei Song; Zhouguang Hui; Luhua Wang
Journal:  Cancer Cell Int       Date:  2022-03-29       Impact factor: 5.722

Review 8.  Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies.

Authors:  Edyta Koscianska; Emilia Kozlowska; Agnieszka Fiszer
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

9.  MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID, and Fragile X syndrome.

Authors:  Wei-Hong Siew; Kai-Leng Tan; Maryam Abbaspour Babaei; Pike-See Cheah; King-Hwa Ling
Journal:  Front Cell Neurosci       Date:  2013-04-15       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.